JAK2 and myeloproliferative neoplasm: Reports described that subjects who were heterozygotes for this haplotype were more likely to acquire the JAK2 V617F mutation with the predisposition SNP allele than on the other chromosome, attributing to subjects a three to four times higher risk of developing an JAK2-positive MPN.